October 2021 • PharmaTimes Magazine • 4-5
Contents
News Review
8. Medicine
10. Healthcare
12. COVID-19
Features
Meeting expectations when it comes to climate change, carbon emissions and sustainability
Oli Hudson looks at three practical implications for pharma companies
Extracting value from the lessons of COVID-19 to empower people living with HIV
Analysis
Are employers doing enough to fulfil their duty of care?
Should pharma companies consider protecting colours that are key to their products?
SmartPeople
PharmaTimes talks to Rick Thompson, chief executive officer at Findacure, and Lucy McKay, chief executive officer at Medics4RareDiseases, about the government's UK Rare Disease Framework
42.
Appointments